Table 1.

Clinical and treatment characteristics of the childhood ALL survivor group

Characteristic	ALL Survivor Group (n = 38)
Sex, Female/Male	21/17
Current age, median (IQR), years	9.0 (7.0–11.0)
Age at diagnosis, median (IQR), years	3.5 (2–5)
ALL subtype, B-cell ALL, n (%)	26 (68.4%)
ALL subtype, T-cell ALL, n (%)	12 (31.6%)
Treatment protocol	AIEOP-BFM ALL 2000
Radiotherapy, n (%)	6 (15.8%)
Radiotherapy dose, median (IQR), Gy	12 (12–18)
Age at diagnosis ≤ 5 years, n (%)	29 (76.3%)
Age at diagnosis ≥ 6 years, n (%)	9 (23.7%)

Data presented as median (IQR) or n (%). IQR Interquartile range